Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis

3 Jul 2019

Abstract excerpt

Importance: Experimental and epidemiological studies implicate the cannabinoid 1 receptor (CB1R) in the pathophysiology of psychosis. However, whether CB1R levels are altered in the early stages of psychosis and whether they are linked to cognitive function or symptom severity remain unknown. Objective: To investigate CB1R availability in first-episode psychosis (FEP) without the confounds of illness chronicity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cannabis and Cannabinoid Research
Share to Forensic Toxicology and Drug Analysis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31268519
DOI: 10.1001/jamapsychiatry.2019.1427

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode PsychosisPMID 31268519Read ↗

Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia.Semantic proximity Read ↗

Cannabinoids and psychosis.Semantic proximity Read ↗

Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot studySemantic proximity Read ↗

Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and SchizophreniaSemantic proximity Read ↗

An insight into the acute effects of cannabidiol on human brain function and their relationship with the brain expression of its molecular targets: a neuroimaging meta-regression analysisSemantic proximity Read ↗

Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms.Semantic proximity Read ↗

Exposure to cannabinoids can lead to persistent cognitive and psychiatric disordersSemantic proximity Read ↗

Role of cannabis and endocannabinoids in the genesis of schizophrenia.Semantic proximity Read ↗

Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous SystemSemantic proximity Read ↗

Decreased Cannabinoid CB1 Receptors in Male Tobacco Smokers Examined With Positron Emission Tomography.Semantic proximity Read ↗

Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography.Semantic proximity Read ↗

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical ResearchSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.